LA JOLLA, Calif., Nov. 28, 2016 (GLOBE NEWSWIRE) -- MyDx, Inc. (OTCQB:MYDX), a rapidly growing chemical detection company that has developed MyDx®, the first multi-use handheld chemical analyzer for consumers, today announced that its recently launched OrganaDxTM and AquaDxTM sensors are continuing to capture the attention of major US television broadcast news stations. This is a direct reflection of both the recent national water crisis as well as the increasing concern amongst consumers that much of our food is being sold with excess amounts of potentially cancer causing pesticides.
Last Friday, November 25, 2016, NBC Channel 6 News aired a report on MyDx’s OrganaDx sensor. In its report, it cited the organic food industry and its 2015 $43 billion addressable market. It quotes organic farmer Rachel Middleton on camera, “I think if people knew what was really in their food, there is no way that they would want it.”
The report continues to show the reporter validating the OrganaDx sensor’s ability to detect an Organic vs. Non-Organic banana. It goes on to describe OrganaDx as, “A consumer friendly, food safety test.”
Additionally, after shipping free AquaDx sensors to Florida residents affected by the Mosaic water crisis in Florida, a story published by ABC Action News indicated the water near Mosaic was safe to drink per the US Military Exposure Guideline for Safety standards used by MyDx. Third party testing lab results that were later reported were in line with MyDx results, indicating the water was safe to drink. One of MyDx’s core features is that it is able to provide reliable and immediate results as was proven in this case.
Commenting on the recent nationwide food and water news coverage, Daniel Yazbeck, Chairman and CEO of MyDx said, “The people on our planet are undergoing a massive shift in consciousness with respect to the quality of what they eat, drink and inhale, and MyDx is right where we want to be – enabling newly conscious consumers to make informed choices with real time affordable testing.”
About MyDx, Inc.
MyDx, Inc. (OTCQB:MYDX) is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user’s hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest. The Company owns a substantial and growing intellectual property portfolio of patents covering its technology. The MyDx CannaDxTM, AquaDxTM and OrganaDxTM sensors are now commercialized, and the AeroDxTM application is next in line. All Sensors will be compatible with a MyDx App that empowers consumers to test the chemical composition of what they eat, drink and inhale. For more information, please visit www.cdxlife.com.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at http://ir.cdxlife.com/all-sec-filings or www.sec.gov.
Last updated on: 29/11/2016
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.